英文報告（１）英文原著
No. Author

Title

Yamada D, Kume H, Miyazaki H, Tanaka M, Takata M, Uemura Y,
1 Morikawa T, Enomoto Y, Suzuki M, Nishimatsu H, Nakagawa T, Fujimura
T, Fukuhara H, Igawa Y and Homma Y.

A prospective randomized controlled study on the Suppression ofProstate Cancer by Naftopidil (SNAP).

Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N,
Akamatsu S, Kamba T, Nakamura T, Ukimura O, Jikuya R, Kishida T,
2 Kakimoto K, Nishimura K, Harabayashi T, Nagamori S, Yamashita S, AraiY, Sawada Y, Sekido N, Kinoshita H, Matsuda T, Nakagawa T, Homma Y,Nishiyama H.
3 Azuma T, Matayoshi Y, Sato Y, Nagase Y.

Vol.

Page

Year

1(1)

1-6

2018

The usefulness of testosterone administration in identifying false-positive
J Cancer Res
elevation of serum human chorionic gonadotropin in patients with germ cell
Clin Oncoltumor.

144

109-115 2018

Effect of dutasteride on castration‑resistant prostate cancer.

Mol Clin Oncol

8133-136 2018

Impact of monthly 120 mg denosumab on bone metabolism in bonemetastatic prostate cancer undergoing androgen deprivation therapy.

Asian Pacific
Journal ofCancer Care2(3)

55-60

2017

The usefulness of testosterone administration in identifying false-positive
J Cancer Res
elevation of serum human chorionic gonadotropin in patients with germ cell
Clin Oncoltumor.

144

109-152018

Kamei J, Ito H, Aizawa N, Hotta H, Kojima T, Fujita Y, Ito M, Homma Y
and Igawa Y.

Age-related changes in function and gene expression of the male andfemale mouse bladder.

ScientificReports82089

2018

Ikebe T, Okuno R, Sasaki M, Kanda Y, Otsuka H, Kawahara R, Ohya H,7 Suzuki M, Uchida K, Nihonmatsu H, Ohnishi M, Working Group for BetaHemolytic Streptococci in Japan.

Molecular characterization and antibiotic resistance of Streptococcus
dysgalactiae subspecies equisimilis isolated from patients withstreptococcal toxic shock syndrome.

J Infect
Chemother

24117-122 20188

Clinicopathological characteristics of patients with upper urinary tract
Urakami S, Inoshita N, Oka S, Miyama Y, Nomura S, Arai M, Sakaguchi K,urothelial cancer with loss of immunohistochemical expression of the DNA Int J Urol
Kurosawa K, Okaneya T.
mismatch repair proteins in universal screening.

25151-156 2018

9Akiyama Y, Maeda D, Morikawa T, Niimi A, Nomiya A, Yamada Y, Igawa Y,
Digital quantitative analysis of mast cell infiltration in interstitial cystitis.
Goto A, Fukayama M, Homma Y.

37

650-7

4Miyakawa J, Taguchi S, Suzuki M, Endo K, Nose Y, Sato T, Ishikawa A,Fukuhara H, Homma Y.

Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N,Akamatsu S, Kamba T, Nakamura T, Ukimura O, Jikuya R, Kishida T,
5 Kakimoto K, Nishimura K, Harabayashi T, Nagamori S, Yamashita S, AraiY, Sawada Y, Sekido N, Kinoshita H, Matsuda T, Nakagawa T, Homma Y,Nishiyama H.
6

JournalPreventive
Medicine andCommunity
HealthNeurourol
Urodyn2018

No. Author
Title
Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J,Taguchi, S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Preoperative chronic kidney disease is predictive of oncological outcome
10Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H,of radical cystectomy for bladder cancer.
Kume H, Igawa Y, Homma Y.
Effect of cerebrospinal fluid shunt surgery on lower urinary tract
dysfunction in idiopathic normal pressure hydrocephalus.

JournalVol.

Page

Year

World J Urol

36249-56

2018

Neurourol
Urodyn3710531059

2018

11Aruga S, Kuwana N, Shiroki Y, Takahashi S, Samejima N, Watanabe A,Seki Y, Igawa Y and Homma Y.

12Kamei J, Yazawa S, Yamamoto S, Kaburaki N, Takahashi S, Takeyama M, Risk factors for surgical site infection after transvaginal mesh placement
Koyama M, Homma Y, Arakawa S, Kiyota H.
in a nationwide Japanese cohort

Neurourol
Urodyn3710741081

2018

13Niimi A, Igawa Y, Aizawa N, Honma T, Nomiya A, Akiyama Y, Kamei J,Fujimura T, Fukuhara H and Homma Y.

Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunnertype interstitial cystitis.

Neurourol
Urodyn3711131119

2018

14 Chen L , Azuma T(equally first author) , Yu W , Zheng X, Luo L, Chen L.

B7-H1 Maintains the Polyclonal T-Cell Response by Protecting Dendritic
Cells from Cytotoxic T Lymphocyte Destruction

Proc Natl Acad
Sci U S A.

11531263131

2018

15

Takada I, Tsuchiya M, Yanaka K, Hidano S, Takahashi S, Kobayashi T,Ogawa H, Nakagawa S, Makishima M.

Ess2 bridges transcriptional regulators and spliceosomal complexes via
distinct interactingdomains.

Biochem
Biophys ResCommun

2597-604 201816

Akiyama Y, Niimi A, Nomiya A, Yamada Y, Nakagawa T, Fujimura T,Fukuhara H, Kume H, Igawa Y, Homma Y.

Extent of Hunner lesions: The relationships with symptom severity andclinical parameters in Hunner type interstitial cystitis patients

NeurourolUrodyn3714411447

2018

17 Fujisaki A, Shigeta M, Shimoinaba M, Yoshimura Y.

Influence of adequate pelvic floor muscle contraction on the movement ofJ Phys Ther Sci 30
the coccyx during pelvic floor muscle training.

544-548 201819 Kitamura T, Suzuki M, Koyama Y, Shigehara K.

Long persistence of human papillomavirus in the skin of the glans penis ofInt J STD AIDS 29
elderly men above 80 years of age.

552-556 2018

Otsuka M, Taguchi S, Nakagawa T, Morikawa T, Maekawa S, Miyakawa J,Clinical significance of random bladder biopsy in primary T1 bladder
20 Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y,cancer.
Homma Y.

Molecular andClinicalOncology

8665-670 2018

No. Author
21Sugihara T, Yasunaga H, Matsui H, Ishikawa A, Fujimura T, Fukuhara H,Fushimi K, Homma Y, Kume H.

22 Kinjo M, Sekiguchi Y, Yoshimura Y, Nutahara K.

Title

JournalVol.

PageYearA skill degradation in laparoscopic surgery after a long absence:
assessment based on nephrectomy case.

Mini-invasivesurgery

2112018

Long-term Persistence with Mirabegron versus Solifenacin in Women with Low Urin Tract10
Overactive Bladder: Prospective, Randomized Trial.
Symptoms

148-152 201825

Oncological and peri-surgical outcomes of radical prostatectomy for nonMakino K, Nakagawa T, Ito E, Kasahara I, Murata T, Fujimura T, Fukuhara
Jpn J Clin
metastatic prostate cancer with prostate-specific antigen level of 50
H, Homma Y.
Oncol
ng/mL or greater.

48485-90

2018

26Aizawa N, Fujimori Y, Kobayashi J, Nakanishi O, Hirasawa H, Kume H,Homma Y, Igawa Y.

3716331640

2018

InternationalSato M, Taguchi A, Fukui Y, Kawata A, Taguchi S, Kashiyama T, Eguchi S,
Blood vessel invasion is a strong predictor of postoperative recurrence in Journal of
27 Inoue T, Tomio K, Tanikawa M, Sone K, Mori M, Nagasaka K, Adachi K,
endometrial cancer.
GynecologicalIkemura M, Domoto Y, Arimoto T, Oda K, Fukayama M, Osuga Y, Fujii T.
Cancer28(5)875-881 2018

Obinata D, Sugihara T, Yasunaga H, Mochida J, Yamaguchi K, Murata Y,
28 Yoshizawa T, Matsui T, Matsui H, Sasabuchi Y, Fujimura T, Homma Y,Takahashi S.

25(7)655-659 2018

Tension-free vaginal mesh surgery versus laparoscopic sacrocolpopexy forpelvic organ prolapse: Analysis of perioperative outcomes using aInt J Urol
Japanese national inpatient database.
Prognostic significance of neutrophil-to-lymphocyte ratio in collecting
duct carcinoma.

Jpn J Clin Oncol 48

30 Azuma T, Sato Y, Ohno T, Azuma M, Kume H.

Serum soluble B7-H4 is a prognostic marker for patients with nonmetastatic clear cell renal cell carcinoma.

PLoS One

25;13(7) e0199719 2018

31 Kinjo M, Yoshimura Y, Kitagawa Y, Okegawa T, Nutahara K.

Sexual activity and quality of life in Japanese pelvic organ prolapse
patients after transvaginal mesh surgery.

J Obstet
Gynaecol Res

4413021307

2018

32

Gastric neuroendocrine carcinoma with positive staining for prostate
Hakozaki Y, Murata T, Yokoyama M, Matsushima H, Ogawa M, Masuda T,cancer markers including prostate-specific antigen and alpha-methylacyl- Urol Case Rep
Hirai Y, Kume H.
CoA racemase.

2067-69

2018

33

Inhibitory effects of silodosin on the bladder mechanosensitive afferent
Aizawa N, Watanabe D, Fukuhara H, Fujimura T, Kume H, Homma Y, Igawa
activities and their relation with bladder myogenic contractions in maleY.
rats with bladder outlet obstruction.

37(6)18971903

2018

29

Taguchi S, Fukuhara H, Miyakawa J, Morikawa T, Naito A, Kawai T,Fujimura T, Kume H.

KPR-2579, a novel TRPM8 antagonist, inhibits hyperactivity of the primary Neurourol
bladder afferent nerves induced by acetic acid in rats.
UrodynNeurourol
Urodyn692-694 2018

No. Author
34

Otsuka M, Kamasako T, Uemura T, Takeshita N, Shinozaki T, Kobayashi
M, Komaru A, Fukasawa A.

35 Kotabe K, Kume H et al.

Title

JournalVol.

Factors predicting biochemical recurrence after radical prostatectomy
among patients with clinical T3 prostate cancer.

Jpn J Clin Oncol 48PageYear760-764 2018

Relationship between rectal bleeding and the absolute dose volume of theOncol Lett
rectum after image-guided radiotherapy for patients with prostate cancer.

16(2)2741–49 201836

365.e9365.e14

36

Oka S, Inoshita N, Miura Y, Oki R, Miyama Y, Nagamoto S, Ogawa K,
Sakaguchi K, Kondoh C, Kurosawa K, Urakami S, Takano T, Okaneya T.

The loss of BAP1 protein expression predicts poor prognosis in patientswith nonmetastatic clear cell renal cell carcinoma with inferior vena cava
tumor thrombosis.

Urol Oncol

37

Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Nakagawa T, Kume H,Igawa Y, Homma Y.

Predictors of Early Continence after Robot-assisted Radical
Prostatectomy.

Low Urin Tract
3Symptoms

287-291 201838

Miyama Y, Morikawa T, Miyakawa J, Koyama Y, Kawai T, Kume H,Fukayama M.

The prognostic value of PD-L1 expression in upper tract urothelial
carcinoma varies according to platelet count.

Cancer Med

743304338

39

Otsuka M, Kamasako T, Uemura T, Takeshita N, Shinozaki T, Kobayashi
M, Komaru A, Fukasawa S.

The prognostic role of the preoperative serum albumin/globulin ratio after
Int J Urol
radical nephroureterectomy for upper tract urothelial carcinoma.

25871-878 201840 Miyamoto Y, Hamasaki Y, Matsumoto A, Doi K, Noiri E, Nangaku M.

Prediction of immunoglobulin M reduction via therapeutic dose of simple
plasma exchange and double filtration plasmapheresis using membrane
separation in patients with hyperviscosity syndrome caused byWaldenstrom macroglobulinemia.

J Clin Apher

33611-615 2018

41 Kamei J, Aizawa N, Nakagawa T, Kaneko S, Kume H, Homma Y, Igawa Y.

Attenuated lipopolysaccharide-induced inflammatory bladder
hypersensitivity in mice deficient of transient receptor potential ankilin1.

Sci Rep

815622

Gains in health utility associated with urinary catheter innovations.

Med Devices(Auckl)11345-351 2018

J Med Econ

21345-952 2018

Clin Exp
Nephrol

2212131223

42

Krassioukov A, Igawa Y, Averbeck MA, Madersbacher H, Lloyd AJ, Bøgelund M, Thiruchelvam N.

Averbeck MA, Krassioukov A, Thiruchelvam N, Madersbacher H, Bøgelund The impact of different scenarios for intermittent bladder catheterization
43 M, Igawa Y.
on health state utilities: results from an internet-based time trade-offsurvey.
44 Yamaguchi T, Higashihara E, Okegawa T, Miyazaki I, Nutahara K.

Optimal equation for estimation of glomerular filtration rate in autosomal
dominant polycystic kidney disease: influence of tolvaptan.

2018

2018

2018

2018

No. Author

Title

JournalVol.

Page

Year

45

Kinoshita Y, Sugihara T, Yasuanga H, Matsui H, Ishikawa A, Fujimura T,Fukuhara H, Ishibashi Y, Fushimi K, Homma Y.

Hospital-volume effects on perioperative outcomes in peritoneal dialysis
catheter implantation: analysis of 2505 cases.

Perit Dial Int

38419-423 201846

Fujimura T, Fukuhara H, Yamada Y, Taguchi S, Sugihara T, Niimi A,Nakamura M, Nakagawa T, Igawa Y, Homma Y, Kume H.

Aggressive cancer behavior of latent Gleason pattern 5 in prostatectomy
specimen.

Anticancer
Research

38（11）

6529-35 2018

47

Mizuno T, Nakamura M, Satoh N, Tsukada H, Matsumoto A, Hamasaki Y,Kume H, Nangaku M.

Patency with antiplatelet treatment after vascular access intervention
therapy:a retrospective observational study.

Renal
Replacement
Therapy4432018[Bone and calcium metabolism associated with malignancy. Bonemanagement of prostate cancer in the novel anti-androgen era.]

Clin Calcium28(11)15351544

2018

Androgen-responsive TRIM36 enhances tumor-suppressive effect byregulating apoptosis-related pathway in prostate cancer.

Cancer Science 109(12)3840-52 2018

Int J Clin Oncol 231140

49 Matsushima H.

50

Kimura N, Yamada Y, Takayama K, Fujimura T, Takahashi S, Kume H,Inoue S.

Kojima T, Nishiyama H, Ozono S, Hinotsu S, Keino N, Yamaguchi A, Sakai Clinical evaluation of two consecutive UroVysion fluorescence in situ
51 H, Enomoto Y, Horie S, Fujimoto K, Matsuyama H, Okamura T, Kanimoto hybridization tests to detect intravesical recurrence of bladder cancer: aY, Oya M, Nonomura N, Naito S, Akaza H.
prospective blinded comparative study in Japan.

2018

英文報告
（２）英文総説
No. Author

Title

Journal1 Fujimura T, Takayama K, Takahashi S, Inoue S.

Estrogen and androgen blockade for advanced prostate cancer in the eraCancersof precision medicine.

2 Yuasa T, Urakami S, Yonese J.

Recent advances in medical therapy for metastatic urothelial cancer.

Vol. Page

Year10e29

2018

599-6072018

Int J Clin Oncol 23

英文報告（３）英文症例報告
No. Author

Title

JournalVol.

Page

Year

1 Oshina T, Azuma T.

Finger metastasis from renal cell carcinoma.

BMJ361

K1592

2018

Urol Case Rep

2067-69

2018

Renal
Replacement
Therapy435

2018

A rare case of de novo large cell neuroendocrine carcinoma of theprostate with long-term survival after cystoprostatectomy and androgen Urol Case Repdeprivation.

2195-972018

2Gastric neuroendocrine carcinoma with positive staining for prostate
Hakozaki Y, Murata T, Yokoyama M, Matsushima H, Ogawa M, Masuda T,cancer markers including prostate-specific antigen and alphaHirai Y, Kume H.
methylacyl-CoA racemase.

3 Miyamoto Y, Hamasaki Y, Matsumoto A, Doi K, Nangaku M.

4Miyakawa J, Suzuki M, Endo K, Nose Y, Sato T, Kishida Y, Tamura K,Morinaga S, Kume H, Homma Y.

A case of refeeding syndrome during intradialytic parenteral nutrition.

5 Okada M, Emoto S, Kaneko M, Yamada D, Nozawa H.

Laparoscopic resection of an urachal abscess caused by migration of afish bone: a case report.

ANZ J Surg

6 Iwaki T, Sugihara T, Omura S, Yoshizaki U, Honda S, Azuma T, Kume H.

Spontaneous regression of a renal mass and multiple lung nodules after
MTX cessation.

IJU CaseReports

2018

116-182018英文報告（４）英文その他
No. Author

Title

JournalVol. Page

Year

1 Taguchi S.

Editorial Comment from Dr Taguchi to Demographics, managements andtreatment outcomes of benign and malignant retroperitoneal tumors inJapan.

Int J Urol

2567-682018

2 Azuma T.

Comparing Sequencing of Abiraterone and Enzalutamide in Men With
Metastatic Castration-Resistant Prostate Cancer: A Retrospective
Study (PROS-17-474).

Prostate

78278

2018

Screening and Diagnosis: How Do We Improve PSA.

ProstateCancer: A
Multidisciplinary
Approach toDiagnosis andManagement.
1st ed.

3 Sugihara T, Kattan MW.

2018